Bio-Techne Executive and Leadership Team

May, 2026

Leadership Overview

Bio-Techne has 8 executives leading key functions including technology, finance, human resources, information technology, financial operations, protein sciences, and diagnostics.

Driven by scientific advancement, Bio-Techne provides innovative tools and bioactive reagents for research and clinical diagnostics, accelerating discoveries in biological processes and disease progression while enabling accurate clinical tests.

Leadership Roles at Bio-Techne

  • Executive Vice President & Chief Financial Officer - James Hippel
  • President, Protein Sciences Segment - William Geist
  • President, Diagnostics & Spatial Biology Segment - Steve Crouse
  • Chief Technology Officer - Gary Latham
  • Vice President, Finance Operations & Chief of Staff - Laurie Gilman
  • Senior Vice President. Chief Human Resources Officer - Brenda Everson
  • Vice President, Information Technology & Chief Information Officer - Matthew Mehlbrech
  • Senior Vice President & Chief Human Resources Officer - Cheryl Bethune
  • James Hippel - Executive Vice President & Chief Financial Officer

    James Hippel, the Executive Vice President & Chief Financial Officer at Bio-Techne, oversees all financial planning, management, and reporting. Hippel directs Bio-Techne's financial strategy, ensuring fiscal responsibility and driving profitable growth in the life sciences sector. This executive leadership position involves managing investments, capital allocation, and financial risk to support the company's mission of providing innovative tools for research and diagnostics. By guiding financial operations, James Hippel ensures the resources are available to fuel scientific discovery and the development of critical diagnostic solutions. Hippel's financial acumen is instrumental in maintaining Bio-Techne's strong market position and enabling its continued expansion into new areas of biological research and clinical application.

    William Geist - President, Protein Sciences Segment

    William Geist, the President, Protein Sciences Segment at Bio-Techne, leads the strategic direction and operational execution for the company's protein sciences division. Geist drives innovation and growth within this segment, focusing on developing and delivering high-quality protein-based tools and reagents for scientific research. This leadership role involves overseeing product development, market strategy, and customer engagement to ensure Bio-Techne's offerings meet the evolving needs of researchers investigating biological processes. By championing advancements in protein science, William Geist directly contributes to accelerating discoveries in areas such as drug development and disease understanding. Geist's leadership ensures the Protein Sciences Segment remains a cornerstone of Bio-Techne's commitment to empowering scientific exploration.
    William Geist

    Steve Crouse - President, Diagnostics & Spatial Biology Segment

    Steve Crouse, the President, Diagnostics & Spatial Biology Segment at Bio-Techne, directs the strategic vision and operational performance of this key business unit. Crouse focuses on advancing Bio-Techne's capabilities in diagnostic solutions and spatial biology, enabling more precise disease detection and research. This executive role involves guiding the development of innovative technologies and products that support accurate clinical tests and deepen the understanding of biological systems at a cellular level. By leading the Diagnostics & Spatial Biology Segment, Steve Crouse ensures Bio-Techne provides critical tools that empower clinicians and researchers to make significant advancements. Crouse's leadership is essential for expanding the company's impact on patient care and scientific discovery.
    Steve Crouse

    Gary Latham - Chief Technology Officer

    Gary Latham, the Chief Technology Officer at Bio-Techne, directs the company's technological vision and innovation strategy. Latham oversees the development and implementation of cutting-edge technologies that enhance Bio-Techne's product portfolio, supporting scientific investigations into biological processes and disease. This leadership role involves guiding research and development efforts to create advanced tools and bioactive reagents for the research and clinical diagnostic communities. By fostering a culture of technological excellence, Gary Latham ensures Bio-Techne remains at the forefront of life sciences innovation, directly contributing to advancements in drug discovery and the accuracy of clinical tests. The CTO's focus extends to exploring new technological frontiers that will shape the future of diagnostics and therapeutic development, ensuring the company's sustained competitive advantage in a rapidly evolving market.
    Gary Latham

    Laurie Gilman - Vice President, Finance Operations & Chief of Staff

    Laurie Gilman, the Vice President, Finance Operations & Chief of Staff at Bio-Techne, manages critical financial operations and provides strategic support to executive leadership. Gilman ensures the efficiency and integrity of financial processes, aligning operational execution with Bio-Techne's overarching business objectives. This dual role involves optimizing financial workflows and acting as a key liaison across departments, facilitating seamless communication and strategic alignment. By overseeing finance operations, Laurie Gilman contributes to the company's financial health and operational effectiveness, supporting the delivery of innovative tools for research and diagnostics. The Chief of Staff function further empowers Gilman to drive key initiatives and enhance executive decision-making, ensuring Bio-Techne's continued growth and impact in the life sciences sector.

    Brenda Everson - Senior Vice President. Chief Human Resources Officer

    Brenda Everson, the Senior Vice President. Chief Human Resources Officer at Bio-Techne, leads all human capital strategies and initiatives. Everson cultivates a robust organizational culture that supports Bio-Techne's mission of advancing life sciences research and diagnostics. This executive position involves developing and implementing comprehensive HR programs, including talent acquisition, employee development, and compensation strategies, all designed to attract and retain top talent. By focusing on human resources, Brenda Everson ensures the company possesses the skilled workforce necessary to drive innovation in biological processes and disease research. Everson's leadership is pivotal in fostering an environment where scientific discovery and the development of critical diagnostic tools can thrive, reinforcing Bio-Techne's position as a global leader.

    Matthew Mehlbrech - Vice President, Information Technology & Chief Information Officer

    Matthew Mehlbrech, the Vice President, Information Technology & Chief Information Officer at Bio-Techne, directs the company's IT infrastructure and digital strategy. Mehlbrech ensures robust and secure information systems that support Bio-Techne's global operations, from research and development to clinical diagnostics. This critical role involves overseeing the implementation of technology solutions that enhance operational efficiency and data integrity across the organization. By managing IT resources, Matthew Mehlbrech enables the seamless flow of information essential for scientific investigations and the development of innovative tools. The CIO's strategic vision is key to leveraging technology for competitive advantage, ensuring Bio-Techne can effectively deliver on its mission to advance life sciences and improve patient outcomes through accurate diagnostics.

    Cheryl Bethune - Senior Vice President & Chief Human Resources Officer

    Cheryl Bethune, the Senior Vice President & Chief Human Resources Officer at Bio-Techne, spearheads the company's human resources strategy and execution. Bethune focuses on building and nurturing a high-performing workforce that drives Bio-Techne's innovation in life sciences and diagnostics. This senior leadership role encompasses talent management, organizational development, and fostering a positive employee experience to support the company's ambitious goals. By championing HR best practices, Cheryl Bethune ensures Bio-Techne attracts, develops, and retains the specialized talent required for cutting-edge research and the creation of advanced bioactive reagents. Bethune's commitment to human capital is vital for sustaining the company's growth and its ability to deliver impactful solutions to the research and clinical communities.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Bio-Techne Top Executives and Leadership Team

    Who leads Bio-Techne?
    Bio-Techne is led by James Hippel (Executive Vice President & Chief Financial Officer), along with executives such as William Geist (President, Protein Sciences Segment) and Steve Crouse (President, Diagnostics & Spatial Biology Segment).
    Who is part of Bio-Techne’s executive team?
    The executive team of Bio-Techne includes leaders such as James Hippel (Executive Vice President & Chief Financial Officer), William Geist (President, Protein Sciences Segment), Steve Crouse (President, Diagnostics & Spatial Biology Segment) and other senior executives.
    How many executives does Bio-Techne have?
    Bio-Techne has 8 executives leading key business areas.
    What roles are included in Bio-Techne’s leadership team?
    The leadership team of Bio-Techne includes roles such as Executive Vice President & Chief Financial Officer, President, Protein Sciences Segment, President, Diagnostics & Spatial Biology Segment, Chief Technology Officer, Vice President, Finance Operations & Chief of Staff.